Publication | Open Access
The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet
266
Citations
36
References
2016
Year
InflammationMetabolic SyndromeLipid DisorderSglt2 InhibitorCardiovascular DiseaseMedicinePhysiologyDiabetesApoe −/− MiceHyperlipidemiaVascular BiologyLipoprotein MetabolismWestern DietPharmacologyAtherosclerosisDyslipidemiaOxidative StressHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1